Successful Use of Intragastric Balloon Therapy as a Bridge to Heart Transplantation
- 1 September 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Obesity Surgery
- Vol. 30 (9), 3610-3614
- https://doi.org/10.1007/s11695-020-04572-7
Abstract
Obesity is an important limiting factor for heart transplantation (HT) in patients with congestive heart failure (CHF). Achieving substantial weight loss is challenging in this population due to activity limitations and fluid retention. Endoscopic bariatric therapies (EBTs) including intragastric balloons (IGB) are effective primary weight loss therapies. IGBs have also been successfully utilized as a bridge therapy prior to liver transplantation and, in one case report, prior to HT. Potential advantages of IGBs in this population include low bleeding risk and less invasiveness as compared to other EBTs and surgery. We report the successful use of IGB as a bridge therapy in two patients with class II obesity and end-stage CHF requiring left ventricular assist devices (LVAD), anticoagulation, antiplatelet, and inotrope therapy.Keywords
This publication has 9 references indexed in Scilit:
- Endoscopic Bariatric Therapies: Intragastric Balloons, Tissue Apposition, and Aspiration TherapyCurrent Treatment Options in Gastroenterology, 2019
- Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-World PopulationClinical Gastroenterology and Hepatology, 2018
- Intragastric balloon for management of morbid obesity in a candidate for heart transplantationThe Journal of Heart and Lung Transplantation, 2017
- Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: Results of a prospective studyObesity, 2016
- Intragastric balloon as a novel modality for weight loss in patients with cirrhosis and morbid obesity awaiting liver transplantationIndian Journal of Gastroenterology, 2016
- The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year updateThe Journal of Heart and Lung Transplantation, 2016
- ASGE position statement on endoscopic bariatric therapies in clinical practiceGastrointestinal Endoscopy, 2015
- ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapiesGastrointestinal Endoscopy, 2015
- The Effect of Body Mass Index on Survival Following Heart TransplantationAnnals of Surgery, 2010